[ Price : $8.95]
FDA approves a crush-resistant formulation of Endo Pharmaceuticals pain drug Opana ER (oxymorphone).[ Price : $8.95]
FDA clears a Meridian Bioscience 510(k) for a new molecular diagnostic test for Group B Streptococcus on its illumigene platform.[ Price : $8.95]
FDA grants fast track status to Celladon Corp. for its investigational drug Mydicar and its use in treating advanced heart failure...[ Price : $8.95]
Public Citizen says a proposal published in Science by former Intel CEO Andrew Grove to restructure clinical trials in the U.S. is...[ Price : $8.95]
FDA says two new large studies involving drugs used for treating Attention-Deficit/Hyperactivity Disorder (ADHD) have not shown an...[ Price : $8.95]
FDA and the European Medicines Agency begin next month relying on each others GMP surveillance inspection reports for certain drug...[ Price : $8.95]
FDA approves a Lannett ANDA for triamterene with hydrochlorothiazide 37.5/25 mg capsules, a generic of SmithKline Beechams Dyazide...[ Price : $8.95]
Nektar begins a Phase 3 global clinical trial to evaluate its NKTR-102 as a single agent in women with metastatic breast cancer.